High incidence of in-hospital pulmonary embolism following joint arthroplasty with dalteparin prophylaxis: A chart review

Thrombosis and Haemostasis

Volumn 103, Issue 1, 2010, Pages 123-128

  Kerr, Jason ^a   Linkins, Lori Ann ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Arthroplasty; Dalteparin; Deep vein thrombosis; Pulmonary embolism; Thromboprophylaxis

Indexed keywords

DALTEPARIN; ESTROGEN; TROPONIN T;

ARTHROPLASTY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DYSPNEA; ECHOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART PALPITATION; HIP ARTHROPLASTY; HOSPITAL PATIENT; HUMAN; INCIDENCE; KNEE ARTHROPLASTY; LUNG ARTERY PRESSURE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYMPTOM; SYNCOPE; TACHYCARDIA; THORAX PAIN; TREATMENT DURATION;

AGED; ANTICOAGULANTS; ARTHROPLASTY; DALTEPARIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; HIP JOINT; HUMANS; INCIDENCE; INPATIENTS; KNEE JOINT; MALE; MIDDLE AGED; ODDS RATIO; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURGICAL PROCEDURES, ELECTIVE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; ULTRASONOGRAPHY; VENOUS THROMBOSIS;

EID: 74249084719     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-07-0438     Document Type: Review

References (10)

1. Douketis JD, Eikelboom JW, Quinlan DJ, et al. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes. Arch Intern Med 2002; 162: 1465-1471.
2. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). The PIOPED Investigators. J Am Med Assoc 1990; 263: 2753-2759.
3. Schiff RL, Kahn SR, Shrier I, et al. Identifying orthopedic patients at high risk for venous thromboembolism despite thromboprophylaxis. Chest 2005; 128: 3364-3371.
4. Eriksson BI, Bergqvist D, Kalebo P, et al. Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial. Lancet 2002; 360: 1441-1447.
5. Eriksson BI, Arfwidsson AC, Frison L, et al. A dose-ranging study of the oral direct thrombin inhibitor, ximelagatran, and its subcutaneous form, melagatran, compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement: METHRO I. MElagatran for THRombin inhibition in Orthopaedic surgery. Thromb Haemost 2002; 87: 231-237.
6. Clayton RA, Gaston P, Watts AC, et al. Thromboembolic disease after total knee replacement: experience of 5100 cases. Knee 2009; 16: 18-21.
7. Parvizi J, Smith EB, Pulido L, et al. The rise in the incidence of pulmonary embolus after joint arthroplasty: is modern imaging to blame? Clin Orthop Relat Res 2007; 463: 107-113.
8. Dahl OE, Andreassen G, Aspelin T, et al. Prolonged thromboprophylaxis following hip replacement surgery - results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin). Thromb Haemost 1997; 77: 26-31.
9. Foley M, Maslack MM, Rothman RH, et al. Pulmonary embolism after hip or knee replacement: postoperative changes on pulmonary scintigrams in asymptomatic patients. Radiology 1989; 172: 481-485.
10. Lemos MJ, Sutton D, Hozack WJ, et al. Pulmonary embolism in total hip and knee arthroplasty. Risk factors in patients on warfarin prophylaxis and analysis of the prothrombin time as an indicator of warfarin's prophylactic effect. Clin Orthop Relat Res 1992; 158-163.